National Cooperative Growth Study in CKD

National Cooperative Growth Study of Nutropin AQ, Nutropin, Protropin, and Nutropin Depot in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End-Stage Renal Disease (ESRD)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00616278

Acronym

NCGS

Enrollment

Registered

2008-02-15

Start date

2005-10-31

Completion date

2010-02-28

Last updated

2017-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Growth Hormone Deficiency

Keywords

Growth Failure AND, Chronic Renal Insufficiency OR, End Stage Renal Disease

Brief summary

The purpose of this study is to learn whether growth hormone being administered to children with Chronic Kidney Disease is effective and if it has any side effects.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Days to 18 Years

Healthy volunteers

Inclusion criteria

* Must be a patient of the UC Davis Medical Center pediatric clinic with Chronic Kidney Disease

Exclusion criteria

* Greater than 18 years old * Not a patient at the UC Davis Medical Center pediatric clinic

Design outcomes

Primary

Measure	Time frame
The primary outcome measures of the NCGS are ongoing safety and efficacy of Genentech GH preparations in pediatric growth disorders for which GH is initiated.	per the study, the pt will be on GH treatement until the physician instructs them to stop

Countries

United States

Outcome results